The team plans to develop markers for personal risk assessment of colorectal cancer, one of the most common and deadliest cancer types. The markers will be based on our body’s natural defenses against cancer, and will include DNA repair, suicide of pre-cancerous cells, and our immune system. These markers and the risk assessment will be used for prevention and early detection of colorectal cancer, with the goal of reducing its incidence and mortality.